Suchergebnisse - "Spiera, Robert F"

PubPharm (35)

1

Comparison of change in end tidal carbon dioxide after three minutes of step exercise between systemic sclerosis patients with and without pulmonary hypertension

enthalten in: Rheumatology | 2017

von Bernstein, E. | Gordon, J. | Spiera, R. | +3

2

Musculoskeletal Involvement in SSc Is Associated with Worse Scores on Short Form-36 and Scleroderma Health Assessment Questionnaire and Lower Tumor Necrosis Factor-α Gene Expression in Peripheral Blood Mononuclear Cells

enthalten in: HSS journal : the musculoskeletal journal of Hospital for Special Surgery | 2016

von Pelrine, E. | Ah-Kioon, M. | Zhang, M. | +3

3

Musculoskeletal Involvement in SSc Is Associated with Worse Scores on Short Form-36 and Scleroderma Health Assessment Questionnaire and Lower Tumor Necrosis Factor-α Gene Expression in Peripheral Blood Mononuclear Cells

enthalten in: HSS Journal ® | 2016

von Pelrine, E. | Ah-Kioon, M. | Zhang, M. | +3

4

Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis

enthalten in: Arthritis research & therapy | 2016

von Johnson, M. | Gordon, J. | Grassetti, A. | +8

5

Using Mass Spectrometry to Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in ANCA-Associated Vasculitis

enthalten in: Analytical chemistry | 2016

von Mills, J. | Cornec, D. | Dasari, S. | +17

6

Dendritic cells maintain dermal adipose–derived stromal cells in skin fibrosis

enthalten in: The journal of clinical investigation | 2016

von Chia, J. | Zhu, T. | Chyou, S. | +12

7

Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis

enthalten in: Arthritis research & therapy | 2016

von Johnson, M. | Grassetti, A. | Taroni, J. | +8

8

Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial

enthalten in: Arthritis research & therapy | 2015

von Gordon, J. | Martyanov, V. | Magro, C. | +6

9

Pulmonary vasculitis

enthalten in: Rheumatic disease clinics of North America | 2015

von Lally, L. | Spiera, R.

10

Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients

enthalten in: The journal of clinical investigation | 2015

von Rice, L. | Padilla, C. | McLaughlin, S. | +13